Predictive markers and molecular mechanism of progressive non-small cell lung cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000033112

Enrollment

Unknown

Registered

2020-05-21

Start date

2020-05-30

Completion date

Unknown

Last updated

2020-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

indolent group:radiomics, single-cell sequence

progressive group:radiomics, single-cell sequence

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients with primary lung adenocarcinoma and squamous cell carcinoma (the maximum diameter reported by CT <=30mm); 2. The patients had at least two chest CT (radiotherapy, chemotherapy, targeting, immunization, surgery) before the treatment of lung cancer and the interval was at least 30 days; 3. Patients with complete focus and clear and divisible edge in CT layer; 4. Patients with complete case data.

Exclusion criteria

Exclusion criteria: Patients with metastatic tumors

Design outcomes

Primary

Measure	Time frame
volume;volume doubling time;	—

Countries

China

Contacts

Public ContactWeimin Li

West China Hospital of Sichuan University

weimi003@yahoo.com+86 18980601009

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026